Specific thromboxane synthetase inhibition and haemostasis in insulin-dependent diabetics.

Abstract

Specific thromboxane synthetase inhibition is associated with a significant fall in abnormal albumin excretion rate in insulin-dependent diabetics (IDDs). This may be due to an effect on haemostasis or changes in renal blood flow. We have studied the effect of a specific thromboxane synthetase inhibitor, UK-38,485, on coagulation parameters in 15 IDDs, at… (More)

Topics

  • Presentations referencing similar topics